Moreover, different authors have investigated BBR action on gut microbiota: BBR treatment modifies gut composition in animal models of obesity, alleviating the inflammation state induced by LPS overproduction and improving energy metabolism and insulin resistance condition [112,113,114]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.